Industry litigation – Page 2
-
Business
Weight-loss drug shortages prompt copycats and counterfeits
Novo Nordisk and Eli Lilly have struggled to meet huge demand for new hormone mimic obesity treatments
-
Business
UK Reach costs set to be slashed under government proposal
Industry may need less hazard data to register chemicals under the regime
-
Business
Three US juries side with cancer victims over Bayer on Roundup
Bayer unit Monsanto has lost its ‘winning streak’ of nine defence verdicts, and the company plans to appeal
-
Business
Chemours is responsible for PFAS pollution, Dutch court rules
Interim decision holds DuPont spin-off liable for environmental damage caused by historical emissions from Dordrecht plant
-
Business
Lapsed US chemical security programme leaves facilities vulnerable
Chemical Facility Anti-Terrorism Standards’ expiry means rules will not be enforced, and companies cannot vet new staff
-
Business
Fines upheld for Advanz Pharma over thyroid drug price increases
UK competition tribunal rules liothyronine pricing ’excessive’ and ‘deliberate’
-
Opinion
Who knew what? And when?
Finding the line between commercially sensitive information and public and environmental protection
-
Business
J&J subsidiary sues more talc researchers
Lawsuit claims another study linking talc use to cancer is fraudulent
-
Business
Environmental groups claim US herbicide reapprovals were illegal
Lawsuit says Environmental Protection Agency ignored serious risks with 2,4-D-containing Enlist products
-
Business
UK diverges from EU rules with cosmetics animal testing ban
UK will no longer allow Reach-required animal tests intended to prove worker safety
-
Business
US supreme court confirms Amgen’s cholesterol antibody patents invalid
Decision could mean patent descriptions need to be even more detailed, and hence expensive
-
Business
DuPont and a senior employee plead guilty to criminal negligence
$16 million in fines and probation related to fatal methyl mercaptan leak at La Porte, US
-
Opinion
Will a court overturn abortion drug’s approval?
Tangle between regulation and politics makes uncomfortable viewing from industry
-
Business
J&J proposes to pay nearly $9 billion to settle talc lawsuits
Company re-files for bankruptcy of a subsidiary in the hopes of resolving tens of thousands of claims its products caused cancer
-
Business
New Jersey sues Dow Chemical and others over 1,4-dioxane pollution
US State wants companies to be held accountable for cleaning up widespread contamination
-
Business
Fragrance firms face coordinated cartel probe
Givaudan, Firmenich, Symrise and IFF raided by competition authorities
-
Business
US government sues chemical firm over chloroprene emissions
Denka disputes claims of ‘unacceptably high’ releases from neoprene manufacturing facility
-
Business
Contaminated cough syrups death toll passes 300 in four months
Deadly glycol contamination discovered in Uzbekistan, following cases in The Gambia and Indonesia
-
Business
J&J subsidiary claims key talc research is fraudulent
Complaint alleges study that helped link talc to cancer contained false information